Press release
Celiac Drugs Market to Witness Robust Expansion Throughout 2015-2021
Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects.
Request Report for TOC @ https://www.persistencemarketresearch.com/toc/4095
Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.
These tests detect auto-antibodies which are present in higher-than-normal levels in the blood of patients who have celiac disease. If the tests show positive results for celiac disease, a small bowel biopsy is done to confirm the diagnosis and determine the level of damage to the lining of the intestine. Approximately, 6 million people suffer from celiac disease in the U.S and Europe. Currently, no drugs, vaccines, or surgical treatments are available for the disease. Gluten free diet is recommended to control the symptoms and prevent long term effects of celiac disease. Immune-modulatory and other therapies are used for the treat the symptoms of celiac disease.
Request To Sample of Report @ https://www.persistencemarketresearch.com/samples/4095
North America dominates the global market for celiac drugs due to rising incidence of celiac disease and lack of treatment options in the region. Asia is expected to show high growth rates in the next five years in global celiac drugs market, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces for the celiac drugs market in developing countries are the large pool of patients, increasing awareness about the disease, and rising government funding in the region.
Increase in healthcare expenditure, changing lifestyles, increasing awareness about healthcare, and increasing number of initiatives by various governments and government associations are some of the key factors driving the growth of the global celiac drugs market. However, complex regulatory frameworks for the approval of drugs in most countries is a major restraint on the growth of the global celiac drugs market.
Innovation of drugs to treat celiac disease would help develop opportunities for the global celiac disease market. The major companies operating in the global celiac drugs market are Alvine Pharmaceuticals, Inc., Alba Therapeutics Corporation, ImmusanT, and the Institute for Protein Design.
Pre Book Full Report @ https://www.persistencemarketresearch.com/checkout/4095
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Celiac Drugs Market to Witness Robust Expansion Throughout 2015-2021 here
News-ID: 887320 • Views: …
More Releases from Persistence Market Research
Artificial Intelligence as a Service Market Forecasted to Grow at 34.6% CAGR, Re …
The Artificial Intelligence as a Service (AIaaS) market has emerged as one of the most transformative segments in the global technology ecosystem. By providing AI capabilities on a subscription or pay-per-use model, AIaaS allows organizations to deploy advanced AI functionalities without the need for significant in-house infrastructure. This model has democratized access to AI, enabling small and medium-sized enterprises to leverage predictive analytics, natural language processing, and machine learning tools…
Server Operating System Market Anticipated to Witness Robust Growth, Reaching US …
The server operating system market is witnessing robust growth, driven by the rapid expansion of data centers and the surging adoption of cloud technologies across enterprises worldwide. Server operating systems form the backbone of modern IT infrastructure, enabling organizations to efficiently manage hardware resources, deploy applications, and maintain high levels of system reliability and security. As businesses increasingly migrate to cloud environments and data-intensive operations grow, demand for powerful, scalable,…
Manufacturing Operations Management Software Industry Anticipated to Witness Rap …
The Manufacturing Operations Management (MOM) software market is rapidly emerging as a cornerstone of digital transformation in the manufacturing sector. As industries increasingly adopt Industry 4.0 practices, the need for advanced solutions that integrate production planning, real-time monitoring, quality control, and process optimization has surged. MOM software enables manufacturers to streamline operations, reduce production downtime, and improve overall efficiency, making it an indispensable tool across automotive, pharmaceutical, aerospace, and consumer…
G.Fast Chipset Market Forecast to Expand with Absolute $ Growth of USD 28.3 Bill …
The G.Fast chipset market has emerged as a pivotal segment within the broadband and telecommunication infrastructure industry, driven by the rising demand for high-speed internet and improved last-mile connectivity solutions. With advancements in fiber-to-the-distribution-point (FTTdp) networks, the adoption of G.Fast chipsets has witnessed unprecedented growth across residential, commercial, and industrial applications. These chipsets enable ultra-fast broadband speeds over existing copper lines, bridging the performance gap between fiber and legacy infrastructures,…
More Releases for Celiac
Celiac Disease Market Emerging Trends and Growth Prospects 2034
Introduction
Celiac disease is a chronic autoimmune disorder triggered by gluten ingestion in genetically susceptible individuals, leading to intestinal damage, malabsorption, and systemic complications. Affecting approximately 1% of the global population, the disease remains underdiagnosed, with many patients suffering from undiagnosed or mismanaged symptoms such as abdominal pain, diarrhea, anemia, osteoporosis, and neurological issues.
The cornerstone of treatment for decades has been the lifelong gluten-free diet (GFD), which requires strict avoidance of…
Celiac Disease Market Revenue Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Celiac Disease Market Size, Share & Trends Analysis Report By Treatments (Infliximab, Larazotide Acetate, Gluten Free Diet), Route Of Administration (Oral And Parenteral), End-Users (Hospitals, Homecare), And Distribution Channels (Hospital Pharmacy, Online Pharmacy, And Retail Pharmacy), Region, Market Outlook And Industry Analysis 2031"
The Global Celiac Disease Market is estimated to reach over USD 1,195.5 Mn…
Celiac Disease Treatment Market
Celiac disease is an autoimmune disorder that affects the small intestine, triggered by the ingestion of gluten-a protein found in wheat, barley, and rye. This condition leads to inflammation and damage in the intestinal lining, which can hinder nutrient absorption and result in various gastrointestinal and systemic symptoms. As awareness of celiac disease grows, so does the demand for effective treatments and dietary solutions. This post delves into the celiac…
Celiac Disease Drugs Market to Record an Exponential CAGR
Celiac Disease Drugs Market report analyses the prospects in the market for several shareholders and aspirants by identifying the high-growth segments, main actions approved by them and Celiac Disease Drugs market recent progressions. The Celiac Disease Drugs market report is prepared after fundamental levels of research regarding the Celiac Disease Drugs Industry.
Celiac Disease Drugs Market by Drugs (First Line of Treatment and Second Line of Treatment) - Global Opportunity Analysis…
Celiac disease Market to Observe Strong Development by 2025
The global Celiac Disease Market is prophesied to rake in a heavy demand on account of three decisive factors such as healthy government initiatives, prevalence of the disease, and increased consumption of foods containing gluten.
Governments of different countries such as the U.K., Canada, New Zealand, Australia, and Argentina and the European Union are expected to accelerative initiatives for the treatment of celiac disease. These governments could provide a strong boost…
Celiac disease market: Global Trends and Forecast Analysis 2025
Celiac disease is an autoimmune disorder in which the surface of the small intestine is damaged by a protein called gluten. Gluten is found in rye, barley, and wheat. Gluten triggers an immune reaction in the small intestine damaging the villi (small finger-like projections in the small intestine which promote absorption). The damage restricts the ability of the body to absorb proteins, nutrients, fats, vitamins, carbohydrates, and minerals. Eventually, this…
